Cure My Disease

Don't miss your cure!

 Log in / Sign up

THE IMPACT OF URINARY INCONTINENCE ON GERIATRIC SYNDROMES IN ELDERLY INDIVIDUALS

NCT ID NCT07813702

NEW Sponsor: MERT UYSAL Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 10, 2026 · Last updated Sep 10, 2026

Summary

The aim of this cross-sectional observational study is to examine the independent associations of urinary incontinence severity and post-void residual urine volume with frailty and other geriatric outcomes in older adults presenting to a urology outpatient clinic with urinary incontinence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of women and men aged 65 years or older presenting to the Urology Outpatient Clinic of Karabuk Training and Research Hospital with urinary incontinence. Individuals who meet the eligibility criteria, are able to mobilize independently, and provide written informed consent will be enrolled consecutively during the study period. All participants will have experienced at least one urinary leakage episode during the previous four weeks and will have an ICIQ-UI SF score of ≥1. No healthy control group will be included.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 65 years or older, * Presence of involuntary urinary leakage according to the International Continence Society definition, * At least one urinary leakage episode during the previous four weeks and an ICIQ-UI SF score of ≥1, * General health status adequate to tolerate the outpatient assessment protocol, * Ability to mobilize independently, * Ability to understand instructions in Turkish and complete the study questionnaires, * Willingness to participate and provision of written informed consent. Exclusion Criteria: * Acute urinary tract infection or acute lower urinary tract symptoms, * History of major pelvic or orthopedic surgery within the previous six months, * Acute musculoskeletal condition that may affect performance during the assessments, * Neurological disease causing severe mobility limitations, including Parkinson's disease or stroke, * Diabetic neuropathy, * Severe cardiopulmonary disease, including New York Heart Association class III-IV heart failure or forced expiratory volume in one second below 30% of the predicted value, * Dementia or severe cognitive impairment, defined as Global Deterioration Scale stage 4 or higher, * Severe visual or hearing impairment that may prevent completion of the assessments, * Terminal illness or active malignancy, * Inability or unwillingness to provide informed consent, * Unwillingness or inability to complete the assessment protocol.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Frailty are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Frailty Sarcopenia Urinary Incontinence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Frailty Frailty syndrome Geriatric syndrome Geriatric syndromes Urinary incontinence Urinary incontinence (UI) Urinary incontinence in geriatric population Urinary incontinence in old age

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Karabuk Training and Research Hospital

    RECRUITING

    Karabük, Merkez, 78050, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.